Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia
사우디아라비아 리야드의 중환자실에 입원한 COVID-19 환자에 대한 Favipiravir의 임상 결과 및 치료 효과 개요
Article
Published on
Journal: Journal of infection and public health [Category] COVID19(2023년), SARS, 임상, 진단, 치료제,
Journal: Journal of infection and public health [Category] COVID19(2023년), SARS, 임상, 진단, 치료제,
[키워드] acute respiratory distress
acute respiratory distress syndrome
age
analyzed
antivirals
approved
ARDS
BMI
body mass
body mass index
Chloroquine
Clinical outcome
collected
Comorbidities
Comorbidity
complications
conducted
control group
Corticosteroid
cough
COVID-19
COVID-19 patient
COVID-19 vaccine
Critically ill
critically ill COVID-19 patients
Critically ill patient
critically ill patients
cytokine
Cytokine storm
diabetes
Diabetes Mellitus
effective
Effectiveness
Efficacy
Efficacy and safety
enrolled
enzyme
Favipiravir
Fever
FIVE
FVP
group
had no
heart disease
hospital
hypertension
ICU
ICUs
IMPROVE
inhibit
intensive care
intensive care unit
intensive care units
ischemic heart disease
Kingdom
majority
male
management
medications
not effective
other treatment
other treatments
overall mortality
P-value
pandemic
Patient
patients with COVID-19
Potential treatment
Randomized
Research
respiratory distress
Respiratory distress syndrome
retrospective cohort study
RNA
RNA polymerase
Saudi Arabia
severe acute respiratory distress syndrome
severe symptoms
Shortness of breath
statistically significant
Symptom
syndrome
the cytokine storm
the disease
the mean
therapeutic
therapeutic efficacy
therapy
Tocilizumab
two groups
Viral
viral infection
viral infections
viral replication
with COVID-19
[DOI] 10.1016/j.jiph.2022.01.013 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jiph.2022.01.013 PMC 바로가기 [Article Type] Article